CJC-1295 5mg + Ipamorelin 5mg

Overview:
The CJC-1295 / Ipamorelin combination is an advanced growth hormone secretagogue (GHS) blend studied for its potential to enhance pituitary signaling, cellular regeneration, and metabolic efficiency. This synergistic complex merges the stabilized GHRH analog CJC-1295 with the selective ghrelin receptor agonist Ipamorelin to create a robust model for GH axis research.

Scientific Background:

• CJC-1295 is a tetrasubstituted GHRH analog designed for enhanced half-life and stability, studied for its ability to stimulate natural GH release and promote IGF-1 expression in research models.

• Ipamorelin is a highly selective ghrelin mimetic that triggers GH release via GHSR activation without affecting appetite or cortisol levels.

Together, these peptides allow detailed exploration of growth hormone regulation, cellular recovery, and anabolic signaling across metabolic and endocrine research fields.

For Laboratory Research Use Only. Not for Human Consumption.